Over the last 40 years, twin packs of EpiPens became a fixture for people and parents with children experiencing severe allergic reactions.
Now, ARS Pharmaceuticals …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
What You Should Know: – A large majority of physicians feel GLP-1s are being overprescribed, according to a new survey from Virta Health, a leader
Share this article Hepion has “begun wind-down activities” for the programme as it assesses alternative strategies. Image credit: Shuttestock/Pasuwan. Hepion Pharmaceuticals has called it quits
Rahul Sharma, CEO of HSBlox The value-based care market is projected to grow to $174 billion by 2032, according to a MarketResearch.biz report released recently.